Journal of Modern Nursing MedicineJPCNS

In recent years, as women play a growing role in social families, the pressure also increases, leading to the increasing incidence of breast cancer. Breast cancer: female common diseases, the incidence of female malignant tumors first, is mainly the phenomenon of breast epithelial cells under the action of a variety of carcinogenic factors, need to actively carry out treatment as soon as possible, otherwise it can threaten the life safety of patients. Three negative breast cancer: mainly refers to the cancer tissue of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2) are negative breast cancer, can account for 15% -20% in all breast cancer, the most common type is invasive ductal carcinoma (medullary carcinoma, adenoid cystic carcinoma, metaplastic cancer), etc., the disease has high recurrence metastasis rate, short median survival, poor prognosis characteristics, is a difficult clinical treatment. Fortunately, we are diseases can be controlled by superb medical means and remove, gersand is the worlds first approved targeted trophoblast cell surface antigen 2 antibody conjugated drugs, with high safety, significant curative effect, the advantage of less adverse reactions, it also brings new hope for three negative breast cancer patients [4-5].

Gosatzumab; Triple-negative breast cancer; Nursing experience